Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × Peripheral Blood Stem Cell Transplantation × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Leukemia, Biphenotypic, Acute 4 Neoplasms 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myeloproliferative Disorders 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Neoplasms 2 Hematologic Diseases 2 Bone Marrow Diseases 2 Anemia, Refractory, with Excess of Blasts 2 Vasculitis, Central Nervous System 1 Teratoma 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Rasmussen subacute encephalitis 1

Interventions

Dexamethasone 12 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 9 fludarabine 9 pomalidomide 8 Lenalidomide 7 Gemcitabine 6 Cytarabine 6 Calcium Dobesilate 6 glofitamab 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 carfilzomib 4 Doxorubicin 4 Capecitabine 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 belantamab mafodotin 3 atezolizumab 3 Vincristine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡